Medical - Healthcare Plans · NYSE
Current Price
$270.90
PE Ratio (TTM)
11.9x
Intrinsic Value
$369
+26.6% margin of safety
As of 2026-11-20, applying a 11.9x earnings multiple to Cigna Corporation's (CI) earnings per share of $22.79 yields a fair value estimate of $369 per share, versus a market price of $270.9.
Fair value from earnings multiples is sensitive to the multiple you choose. Across the sensitivity grid the estimate spans $280.84 to $471.18. This is a relative estimate anchored to earnings, not a statement of fact. For a cash flow based view, see the intrinsic value estimate on the DCF page.
How the PE model works · Recalculate in PE mode · CI intrinsic value (DCF view)
At $270.9, CI trades about 26.6% below its PE-based fair value estimate, a modest discount to its earnings power, though not enough to call it cheap outright.
COMPETITIVE MOAT
↑Extensive Provider Network
Cigna's vast network of doctors and hospitals creates significant switching costs for members. This scale makes it difficult for competitors to replicate and offers members broad access to care.
↑Brand Recognition and Trust
Cigna's established brand fosters trust among consumers and employers seeking reliable health insurance. This reputation is built over years and difficult for newer entrants to quickly achieve.
↑Data Analytics and Scale
The company leverages large datasets to optimize care management and pricing. This scale allows for more sophisticated analytics, leading to better health outcomes and cost efficiencies.
INVESTMENT RISKS
↓Healthcare Cost Inflation
Rising medical costs can erode profit margins if not adequately passed on to customers or managed through efficiency gains. This is a persistent challenge for all health insurers.
↓Cybersecurity Threats
As a holder of sensitive health data, Cigna is a prime target for cyberattacks. A breach could lead to significant financial penalties and reputational damage.
↓Member Retention and Churn
While switching costs exist, employers and individuals can still change health plans, especially if competitors offer significantly lower prices or better perceived value. Maintaining membership is crucial.
Base case
Intrinsic Value
$369
Margin of safety
+26.6%
Expected annual return
+6.4%
Base case assumptions: 8.9% annual earnings growth, 11.89x target PE, 10% discount rate, 5 year projection. Data as of 2026-11-20.
This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Cigna Corporation respond.
Open PE Calculator for CICigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
PE Ratio (TTM)
11.9x
PEG Ratio
n/m
Earnings Yield
8.41%
ROE (TTM)
14.1%
Revenue/Share (TTM)
$1089.53
Dividend Yield
2.28%
Debt/Equity
0.72x
The trailing twelve-month PE ratio of CI reflects how much investors pay per dollar of Cigna Corporation's earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
CI's PE of 11.9x combined with a PEG ratio of -38.82 provides a growth-adjusted perspective. CI has negative earnings, so its PE and PEG ratios are not meaningful here and cannot tell you whether the stock is over or undervalued. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Cigna Corporation using PE: (1) Compare the current PE (11.9x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (-38.82) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
CI's PEG ratio is -38.82, calculated by dividing the PE ratio (11.9x) by the expected earnings growth rate. Because CI has negative earnings, its PEG ratio is not meaningful and should not be read as a sign of under or overvaluation. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how CI is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value CI with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-11-20. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.